Dr. Tagni Outlines Five Understated Health Risks Linked to Menopause

The end of a woman's reproductive phase is typically defined by the permanent cessation of menstrual periods for at least 12 months, a standard metric reported by the CDC. However, medical professionals note that the physiological changes accompanying menopause extend far beyond the common symptoms of hot flashes and mood shifts. Dr. Carine-Ange Tagni, a board-certified obstetrician and gynecologist, recently detailed five specific health implications that are frequently overlooked in public discussions.

The Centers for Disease Control and Prevention state that the average age for menopause in the United States is 51 or 52. During this transition, the ovaries reduce the production of estrogen and progesterone. The National Institutes of Health reports that these hormonal changes can trigger symptoms lasting anywhere from two to eight years, though the specific duration and intensity vary significantly from one patient to another.

Dr. Tagni identified recurrent urinary tract infections as a primary concern often misattributed to poor hygiene. She explained that estrogen helps maintain the tissues and healthy bacteria in the vagina and lower urinary tract. As estrogen levels drop, these protective barriers weaken, increasing the risk of infection. Citing the 2025 Genitourinary Syndrome of Menopause guideline, she noted that low-dose vaginal estrogen can help reduce future infections in appropriate patients, whereas antibiotics treat the bacteria but do not reverse the tissue changes caused by menopause.

Vaginal discomfort is another area where diagnosis is critical. Dr. Tagni pointed out that burning or rawness during menopause is not always the result of a yeast infection. These sensations can stem from genitourinary syndrome of menopause, a condition where falling estrogen affects tissue moisture and sensitivity. Treating presumed yeast infections without examining the tissues may miss the underlying cause of the discomfort.

The physical symptoms of menopause are also linked to mental health outcomes. In a large matched-control study, women with vulvovaginal atrophy showed higher rates of anxiety and depression compared to controls. The data indicated that 16.6 percent of women with the condition reported anxiety, compared to 11.3 percent in the control group, and 23.9 percent reported depression, compared to 18.9 percent in the control group. Dr. Tagni emphasized that this association provides a strong reason for clinicians to evaluate emotional well-being when treating intimate symptoms.

Strength training offers potential benefits for cognitive function during menopause. Dr. Tagni noted that skeletal muscles release molecules called myokines that communicate with other organs, including the brain. A small 2026 randomized pilot trial found that perimenopausal and early postmenopausal women who engaged in nine months of resistance training showed improvements in memory and mental flexibility. While this is promising early evidence, it does not prove that exercise prevents Alzheimer's disease.

Finally, changes in body composition often manifest as an increase in abdominal fat, commonly referred to as the menopause belly. Dr. Tagni explained that this is not merely a result of weight gain. Around menopause, fat is more likely to accumulate as visceral fat inside the abdomen, surrounding the organs. This type of fat is metabolically active and is associated with inflammatory signaling, insulin resistance, and increased cardiovascular risk, as observed in the SWAN Heart research.

These physiological shifts demonstrate that the menopause transition involves complex systemic changes rather than isolated symptoms. The reduction in estrogen and progesterone alters tissue health, fat distribution, and organ communication. While some changes are well-documented, others remain subjects of ongoing research, such as the specific mechanisms by which muscle activity influences brain function in this demographic.